Investment Q&A

Q: Further to Arnold’s question of March 9th. Enbridge’s stock is holding in quite well? Is this likely a result that investors believe there is a significant likelihood a positive resolution or compromise will be reached regarding Line 5? What is your best guess? Thanks.

Q: Hello, Are there any listed companies you would recommend in the carbon capture business? Thank you.

Regards,

Shyam

Q: Thoughts on the proposed merger of SES and TEV?

Q: I have a 4% position in Air Canada. I've made over 30% so far. I think it still has room to run as the economy opens up, but who knows. At what point would you start to lighten up?

Jason

Q: I am down 25 percent on Docebo. Would you sell, hold, or average down. Thanks

Q: In a broadly diversified portfolio, for a risk tolerant investor, how would you rate these stocks on a 1 - 10 scale, with a "10" meaning for sure you want this stock in your portfolio, and a "1" being you absolutely do not want this stock in your portfolio. Long term time horizon, looking for growth. AT, CTS, DCBO, DOC, DND, NVEI, TIXT, WELL, WISH.

Q: I believe both companies, Europe technologies and Rubicon are on the cve. I'd like to know what your take is on both companies. Do you know what their latest results were and what the outlook for both stocks is. Is there anything special I should know in regards to their business and competition. Thanks

Q: I am a buy and hold investor. For an unregistered account which of the above would you recommend and why?

Ron

Q: The majority of our utility holdings are in FTS /AQN, and when looking at value metrics: EV/Rev, p/b, forward p/e and yield, these 2 stocks appear to rank highest of the stocks listed above. NPI seems to be 3rd best in value, but it does have a higher p/b ratio. We also hold the following utilities in decreasing weight: BEP.UN, NPI and INE. We need to trim SU/ENB and want to add more to some or all of the latter 3 utilities - would you add the most to BEP.UN then NPI or focus on just BEP.UN? INE appears to be a bit over-valued at this time. Should we continue to hold INE, sell or add on more significant dip? We income/growth investors with 10+ year time horizon.
Thanks!!

Q: Hello,

The financial sector are at 52 week highs, do you see an issue with stepping in at these prices ? Would you consider one of the major banks and perhaps GSY as an alternate to the big banks with exposure to the financial sector ?

Thanks,
Robbie

Q: Hi,
TFII is the only stock in the BE portfolio that I don't own, but I do own MU. Should I sell MU to buy TFII, or should I stick with MU.
Thanks

Q: Not a question. There have been a number of questions regarding Topicus.com's ACB.
There is a thread started in the Forum.

Q: HI
I am looking at cleaning up my portfolio and removing stocks that have not performed as expected . What is your take on the five stocks listed . Should I have a longer view on these stocks

Thank you

Howard

Q: Could you comment on the announcement today from Artis. Why move to a publicly tradable private equity? Who benefits from this? Presumably it would still be on the TSX? I also wonder why they would sell off what seems to be the best portion of their portfolio? I hold a small position in Artis, but with significant capital gains (which I prefer not to realize right now). What is your view of Artis going forward - hold or sell?
Thank-you

Q: on Tuesday priced an underwritten marketed public offering of about 9.1 million of its common shares in the US and Canada at $27.50 per share.... how will this affect current stock price

Q: Buy, sell or ?

Q: Could you please comment on LIF's March announced Special Dividend @ $1.00/shr and how that affects the expected rate of return in 2021?
Any thoughts on likelihood of a repeat payment at year end?

Q: Like others I have been struggling with what is the real book cost I should use for the Topicus (TOI) shares I received as a spin-out from CSU.

My broker (RBC Direct Investing) shows it as 0.0001/share. Based on what I read here I tried to convince RBC to adjust it to $63.30 (Feb 2nd closing price) as suggested by Peter. RBC would not change it unless I fill out a form and provide proof that it should be $63.30.

So tonight I emailed Constellation Software this question. Within 30 minutes (at 8pm) I received a response from Jamal Baksh (CFO at CSU). He said:

“It is our assertion that the value of the business has been ascribed to the preferred shares and hence the value ascribed to the subordinated voting shares (“SVS”) is nominal (close to zero). The future growth of the business will result in the appreciation of the SVS. As described in the prospectus the preferred shares will get converted to SVS at which time the SVS will reflect the full value of the business.

I’ve attached a copy of the bulletin from CDS which shows the cost at C$0.00015641/share.

Note that you are better off from a tax perspective having a nominal dividend and a larger capital gain.”

The attachment he sent says this:
“06JAN2021

UPDATE: FAIR MARKET VALUE

CDS has been advised by the agent of an update to the FMV per subordinate voting share as follows:

CAD 0.00015641 based on 0.0001 EUR converted to CAD at 1.5641

CDS will credit participants with the shares upon receipt from the agent.”

I do have the subordinate voting shares (SVS) of TOI. So I guess I really have a 69 million % unrealized capital gain on these shares. Looks great on paper.

Paul

Q: Morning 5i Team, in order to add some torque to the fixed income portion of an RRSP, what do you think of the combination of these two @50% each? Better alternatives?
Thanks, Lavern

Q: Hi 5i team,
This is not a question. Regarding the book value of TOI , it's best to confirm with CSU. Apparently, the book value for the stock distribution is indeed close to zero per CSU client relation.